The official guide price of Pien Tze Huang for "Moutai in Medicine" is 590 yuan per capsule.

  On September 30th, #黃牛軍廣報國網陀# was listed on Weibo's hot search list.

According to media reports, we learned from several "scalpers" that since September last year, the price of Pien Tze Huang lozenges has been falling. The official guide price for Pien Tze Huang lozenges in 3g*1 capsules is now as low as 400 yuan per capsule. Yuan.

  In the flagship store of Taobao Pien Tze Huang Pharmacy, 3g*1 capsules of Pien Tze Huang are on sale normally, the price is 590 yuan.

The page shows that the Pien Tze Huang lozenges have a relatively sufficient supply, with monthly sales exceeding 20,000 units.

High-priced hype goes down

  As a nationally renowned "magic medicine", the history of Pien Tze Huang can be traced back to the Jiajing period of the Ming Dynasty more than 500 years ago.

  According to literature records, an imperial doctor who was dissatisfied with the tyranny of the tyranny fled to Zhangzhou with the prescription of Pien Tze Huang. Later, an epidemic broke out there. The imperial doctor stole the top-secret formula of the palace and added his own unique craftsmanship to refine Pien Tze Huang. Later, Pien Tze Huang It has been passed down, and this is the "famous medicine" Pien Tze Huang today.

  The raw materials of Pien Tze Huang are also very scarce.

Due to confidentiality requirements, there are currently four main ingredients disclosed by Pien Tze Huang, namely musk, bezoar, snake gall, and notoginseng.

Among these four components, musk is an extremely valuable Chinese herbal medicine, which mainly comes from the glandular sac secretion of male musk deer, and the musk musk deer forest musk deer is an endangered and precious first-class protected animal in the country, and the raw materials must use endangered animals. Enough to see Pien Tze Huang's "Jin Gui".

At the same time, Pien Tze Huang is the only Chinese medicine in China that has obtained the certification of "National Top Secret Class Secret Formula".

  As a medicine, Pien Tze Huang's main functions are "clearing heat and detoxifying, cooling blood and removing blood stasis, reducing swelling and relieving pain. It is used for acute and chronic viral hepatitis, carbuncle and furuncle caused by heat toxin and blood stasis, unknown swollen poison, traumatic injury and various inflammations".

  Statistics from Southwest Securities show that from 2004 to 2020, the prices of Pien Tze Huang lozenges were raised 19 times.

From 2004 to 2020, the retail price of Pien Tze Huang has risen from 325 yuan per capsule to 590 yuan per capsule, a price increase of 81.54%.

From the ex-factory price point of view, the price of Pien Tze Huang lozenges has been raised 10 times since 2004, from RMB 125 per tablet in 2004 to RMB 390 per tablet in early January 2020, a price increase of 212%.

  Since the end of March last year, Pien Tze Huang's medicines have become very popular, and the situation is unprecedented. Citizens need to book with their ID cards, and the 590 yuan / piece has been sold to 1,600 yuan / piece by scalpers, which is still "hard to find".

  In response to the hype problem, Pien Tze Huang responded on the interactive platform last year and pointed out that in response to the recent market situation, the company has taken a series of measures to stabilize the supply, expand sales channels, increase the supply of Pien Tze Huang capsules with the same quality and effect as Pien Tze Huang lozenges, and resolutely maintain market order. .

In May and July 2021, Pien Tze Huang Pharmacy Tmall flagship store and Pien Tze Huang Pharmacy JD flagship store will be added to expand online sales channels.

  Entering 2022, Pien Tze Huang's hype is showing signs of stalling.

Some media have learned from a number of "scalpers" that since September last year, the price of Pien Tze Huang lozenges has been falling. The official guide price for Pien Tze Huang lozenges in 3g*1 capsules is now up to 570 yuan per capsule. , the minimum is only 400 yuan.

  The reporter found in the flagship store of Taobao Pien Tze Huang Pharmacy that 3g*1 capsules of Pien Tze Huang are normally sold at a price of 590 yuan, but each order is limited to 4 pieces.

The page shows that the Pien Tze Huang lozenges have a relatively sufficient supply, with monthly sales exceeding 20,000 units.

Offline, some media asked the clerks of many Pien Tze Huang experience centers in southern China, and they all said that the current supply of Pien Tze Huang tablets is relatively sufficient, and consumers can come to buy and pick up the goods at any time without making an appointment.

  On September 30th, #黃牛軍廣報國網陀# was listed on Weibo's hot search list.

Stock prices continue to fall

  As a white horse stock in the market, since 2015, Pien Tze Huang's share price has been in an upward channel for a long time.

Under the influence of the hard-to-find medicine of Pien Tze Huang last year, Pien Tze Huang's share price rose strongly. On July 21 last year, the share price once surged to a historical high of 491.88 yuan per share, with a market value approaching 300 billion yuan.

  As the stock price rose, from August to November 2021 in the primary market, the controlling shareholder Jiulongjiang Group reduced its holdings of Pien Tze Huang shares by 6,033,100 shares through centralized bidding transactions. billion.

This is also the first time that Jiulongjiang Group has reduced its holdings since Pien Tze Huang went public.

  At the same time, Pien Tze Huang's performance has also risen.

Pien Tze Huang's 2021 annual report shows that last year, the company achieved operating income of 8.022 billion yuan, a year-on-year increase of 23.2%; net profit attributable to the parent was 2.431 billion yuan, a year-on-year increase of 45.46%, a record high.

Regarding the increase in performance, Pien Tze Huang said that it was mainly due to the increase in the opening of online channels in Tmall and Jingdong flagship stores during the reporting period.

  In the first half of 2022, Pien Tze Huang achieved revenue of 4.423 billion yuan, a year-on-year increase of 14.91%; net profit attributable to the parent was 1.314 billion yuan, a year-on-year increase of 17.85%.

In terms of products, the revenue of liver disease drugs, mainly Pien Tze Huang, was 1.97 billion yuan, with a gross profit margin of 80.49%; the revenue of cardiovascular and cerebrovascular drugs, mainly Angong Niuhuang Pills, was 123 million yuan, a year-on-year increase of 171%. The gross profit margin was 47.63%, a year-on-year increase of 189.42%.

  However, as Pien Tze Huang's high selling price gradually subsided, Pien Tze Huang's share price began to drop significantly.

On September 22, "Moutai in Medicine" Pien Tze Huang plummeted by more than 7% throughout the day, arousing market attention.

On September 26, Pien Tze Huang's share price hit a new low of 246.01 yuan during the year.

Wind data shows that since the beginning of this year, Pien Tze Huang's share price has fallen by 39%, and its market value has evaporated by more than 100 billion yuan.